Amarin Corporation plc, each representing one Ordinary Share (AMRN): Price and Financial Metrics
Amarin Corporation plc, each representing one Ordinary Share (AMRN)
Today's Latest Price: $4.60 USD
Updated Nov 25 7:55pm
Add AMRN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
AMRN Stock Summary
- The price/operating cash flow metric for Amarin Corp Plc is higher than 98.32% of stocks in our set with a positive cash flow.
- For AMRN, its debt to operating expenses ratio is greater than that reported by just 7.35% of US equities we're observing.
- With a year-over-year growth in debt of -73.05%, Amarin Corp Plc's debt growth rate surpasses merely 3.56% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Amarin Corp Plc, a group of peers worth examining would be EVER, HAYN, TREE, VG, and BOOM.
- Visit AMRN's SEC page to see the company's official filings. To visit the company's web site, go to www.amarincorp.com.
AMRN Stock Price Chart Interactive Chart >
AMRN Price/Volume Stats
| Current price | $4.60 | 52-week high | $26.12 |
| Prev. close | $4.48 | 52-week low | $3.36 |
| Day low | $4.46 | Volume | 6,525,100 |
| Day high | $4.68 | Avg. volume | 9,827,133 |
| 50-day MA | $4.58 | Dividend yield | N/A |
| 200-day MA | $7.35 | Market Cap | 1.80B |
Amarin Corporation plc, each representing one Ordinary Share (AMRN) Company Bio
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company was founded in 1989 and is based in Dublin, Ireland.
AMRN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $4.60 | $0 | -100% |
We started the process of determining a valid price forecast for Amarin Corp Plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Amarin Corp Plc ranked in the 0th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Amarin Corp Plc ended up being:
- Its compound free cash flow growth rate, as measured over the past 0.52 years, is -0.94% -- higher than only 0.19% of stocks in our DCF forecasting set.
- Relative to other stocks in its sector (Healthcare), Amarin Corp Plc has a reliance on debt greater than merely 10.01% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -100% |
| 1% | -100% |
| 2% | -100% |
| 3% | -100% |
| 4% | -100% |
| 5% | -100% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as AMRN, try AGHC, ALC, ATRS, MOR, and PACB.
Loading social stream, please wait...